Lipid Insights

National Lipid Association
  • 5,0 (1)
  • Medizin
  • Zweimonatlich

Tune in to the NLA's podcast series to hear expert speakers discuss key topics in lipidology. 

  1. 1. Juli

    S7E8: Thinking Long-Term: LDL Exposure, Longevity Medicine, and the Future of Cardiovascular Prevention

    How do we move the needle on cardiovascular prevention — not just in the clinic, but across entire systems and communities? In this episode of Lipid Insights, host Alan S. Brown, MD, MHA, MNLA sits down with Nihar R. Desai, MD, MPH, FNLA for a forward-thinking conversation on long-term LDL exposure and what it truly means to practice longevity medicine. From the power of imaging as a patient education tool to the momentum behind the 2026 dyslipidemia guidelines, Dr. Desai shares his vision for a healthcare landscape where patients are empowered, systems are hardwired to deliver better care, and public education closes the gap between what we know and what gets done. A timely and thought-provoking listen for any clinician committed to moving cardiovascular prevention forward.

    28 Min.

  2. 10. Mai

    S7E7: National Lipid Day Special: The Lipid Doctor’s Truths Every Clinician Should Know

    What does your patient's lipid panel actually tell you and what is it missing? In this special National Lipid Day episode of Lipid Insights, host Peter H. Jones, MD, MNLA, sits down with Thomas Dayspring, MD, FACP, MNLA — widely known as "The Lipid Doctor" — for a conversation that challenges some of medicine's most entrenched assumptions about lipid risk assessment. From the clinical superiority of ApoB over LDL-C and the underrecognized atherogenic burden of Lipoprotein(a), to why HDL-C should no longer be treated as a therapeutic target, Dr. Dayspring delivers evidence-based truths that have direct implications for how clinicians assess and manage cardiovascular risk. If you order lipid panels, counsel patients on cholesterol, or manage ASCVD risk in any capacity — this episode is essential listening. Follow @drlipid on X (Twitter) and LinkedIn. https://x.com/Drlipid https://www.linkedin.com/in/thomas-dayspring-md-facp-fnla-3aaa876/

    58 Min.

  3. 16. Apr.

    S7E6: Identification of Rare Lipid Disorders in Children

    In this episode of Lipid Insights, host Peter H. Jones, MD, MNLA sits down with Nivedita Patni, MD, of the Department of Pediatrics at UT Southwestern Medical Center in Dallas, TX, to explore the complex landscape of pediatric dyslipidemia. Dr. Patni walks through the critical importance of tailoring management to etiology, the long-term cardiovascular and metabolic risks that hang in the balance, and why early identification is everything. Drawing on case studies and evidence-based management strategies, Dr. Patni shares practical implementation guidelines for clinicians navigating these challenging diagnoses — including the challenges that make rare lipid disorders in children so easy to overlook and so difficult to treat. She also highlights the essential role of multidisciplinary care, bringing together endocrinology, dietetics, and family support to deliver truly individualized treatment. Whether you're seeing these patients regularly or encountering them for the first time, this episode will sharpen your clinical lens and equip you with actionable strategies to make a difference early.

    28 Min.

  4. 3. Apr.

    S7E5: Tackling Childhood Obesity: Innovative Strategies for a Healthier Future

    Childhood obesity is one of the most pressing public health challenges of our time — and its long-term cardiovascular and metabolic consequences make it essential territory for lipidologists and clinicians alike. In this episode of Lipid Insights, host Peter H. Jones, MD, MNLA sits down with Casey Berman, MD to explore the full picture: how childhood obesity is defined, why its prevalence continues to rise, and the behavioral, societal, and genetic factors fueling the epidemic. They also dive into associated comorbidities and the latest prevention and management strategies — from lifestyle modifications and pharmacotherapy to the evolving role of bariatric and metabolic surgery. A must-listen for any clinician looking to better support their youngest patients.

    27 Min.

  5. 17. März

    S7E4: 2026 ACC/AHA Cholesterol (Dyslipidemia) Guidelines: Clinical Meaning for Lipidologists

    Join host Dr. Peter H. Jones for a special episode of Lipid Insights discussing the 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia. Dr. Jones is joined by guideline author and NLA Past President Dr. Joseph Saseen and NLA President-Elect Dr. Dinesh Kalra to break down what clinicians need to know. From the restoration of LDL-C treatment goals and major conceptual shifts from the 2018 guideline, to primordial and primary prevention, risk assessment, special populations, and real-world implementation challenges, this episode covers it all. The panel also explores the guideline's expanded scope beyond LDL-C to include triglycerides, Lp(a), ApoB, and more. This is a must-listen episode for anyone involved in dyslipidemia management. Read the Guidelines here: https://www.jacc.org/doi/10.1016/j.jacc.2025.11.016

    42 Min.

  6. 5. März

    S7E3: LDL-C Reduction in Primary Prevention: Insights from a New Meta-Analysis

    In this episode of Lipid Insights, we explore the NLA's recent expert meta-analysis, "Low-density lipoprotein cholesterol lowering and risk of major adverse cardiovascular events in primary prevention trials."   Lead author Dinesh K. Kalra, MD, MBA and key author Kevin C. Maki, PhD, CLS, MNLA join host Alan S. Brown, MD, MHA, MNLA to examine the relationship between LDL-C reduction and major adverse cardiovascular events in primary prevention trials. Together, they break down the findings, clinical implications, and why early LDL-C lowering remains central to preventing first cardiovascular events. Read the meta-analysis: https://www.lipidjournal.com/article/S1933-2874(26)00039-5/fulltext

    22 Min.

  7. 19. Feb.

    S7E2: Addressing Obesity and Weight Loss Challenges: Implications for Cardiometabolic Health

    In this episode of Lipid Insights, host Dr. Peter Jones is joined by renowned experts Robert H. Eckel, MD, FNLA and Samuel M. Kim, MD for a thoughtful discussion on the complex relationship between obesity, weight loss, and cardiometabolic health.

    25 Min.

  8. 29. Jan.

    S7 E1: Changing the FH Playbook: Diagnosis and Treatment Updates from the NLA

    Hosted by Dave Dixon, PharmD, CLS, FNLA, this episode features an in-depth discussion with three key authors of the NLA’s new statement providing updated guidance on diagnosis, management, and treatment of FH. Together, they review the most important updates in the new guidance, including recommendations for earlier identification, the role of genetic testing and cascade screening, updated LDL-cholesterol treatment targets, and the integration of newer lipid-lowering therapies. The conversation also addresses practical considerations for managing FH across the lifespan, from pediatric care to special populations, with a focus on translating evidence-based recommendations into real-world clinical practice. You can watch the video version of this podcast HERE. You can read the official NLA consensus statement published open-access in the Journal of Clinical Lipidology HERE. Podcast listeners can claim credit for listening to the podcast HERE. This podcast has been approved for AMA PRA Category 1 Credit™. This activity is eligible for ACPE, ANCC, and CDR credit.

    1 Std.
Alle anzeigen (43)

Info

Tune in to the NLA's podcast series to hear expert speakers discuss key topics in lipidology. 

Informationen

  • Erstellt von
    National Lipid Association
  • Jahre aktiv
    2020 - 2026
  • Folgen
    43
  • Bewertung
    Unbedenklich
  • Copyright
    © 2026 National Lipid Association
  • Sendungswebsite
    Lipid Insights

Das gefällt dir vielleicht auch